提交活动资讯

2022年北美更年期学会年会

生殖医学展览会|妇产年会|儿童活动|老年医学博览会|


会议地点: 美国 亚特兰大
会议时间: 2022年10月12日至15日
行业: 生殖医学|妇产|儿童|老年医学会议

会议简介:

2022年北美更年期学会(NAMS)年会将于2022年10月12日至15日在美国亚特兰大举行,预计有超过1200名专业人士出席会议。

北美更年期学会(NAMS)成立于1989年,是北美洲领先的非营利性多学科组织,致力于通过对更年期和健康老龄化的了解,提高所有中年及以后女性的健康和生活质量。NAMS现拥有2000多名宣在该领域知名的多学科成员,他们是来自于医学、护理、社会学、心理学、营养学、人类学、流行病学、药学和教育方面的临床和基础科学专家。NAMS推出了多个更年期女性健康指南,成为其他国家制定自身指南的重要参考资源。

NAMS 2022 - North American Menopause Society Annual Scientific Meeting
Date: October 12-October 15, 2022
Venue: Hyatt Regency Atlanta, GA USA

 

摘要征集:

点此提交摘要>>>Submit Abstract>>>

The deadline for regular submission is April 30, 2022. The deadline for late-breaking submission is July 1, 2022. Guidelines follow:

  • Each author may submit up to five abstracts for consideration.
  • There is a limit of 4,545 characters for the text of your submission. The character count includes spaces, title, authors, institutions, tables, and images. You will be advised of your character count usage throughout the submission process as you save and move to the next step. Your character count will also be displayed in the bar at the top of your submission.
  • Information submitted for consideration must not be identical to that presented at any meeting prior to the NAMS Annual Meeting and the study must not have been published as of the submission date.
  • Authors who wish to be considered for a New Investigator Award must have earned their degree within seven years, and not previously been given this award. Proof of eligibility is required.
  • All abstracts presented at the NAMS Annual Meeting will be published in Menopause.
  • NAMS reserves the right not to review an abstract, or not to publish an abstract in Menopause, if the abstract submission does not conform to all requirements.
  • Abstracts must be submitted in English, in a structured format.
  • Late-breaking submissions must be truly late-breaking, meaning the material was not available for submission by the regular deadline of April 30, 2022.

Types of Presentations

  • Oral Presentation: The top scoring abstracts will be invited to be presented from the podium in a Scientific Session held during the NAMS Annual Meeting.
  • Poster Presentation: All other abstract submissions will be considered for poster presentation during the Poster Session. Up to three Poster Prizes will be awarded, with a top prize of $1,000.

Review and Selection Process

All abstracts are subjected to a blinded review by three independent members of the NAMS Abstract Review Committee. After being sent to the Abstract Review Committee for review, submissions may not be altered. Abstracts will be scored as follows:

  • Approach
  • Innovation
  • Impact of study findings on field of menopause
  • Clarity

Approach: Is the study design appropriate to the study aims? How strong are the research methods with respect to selection of participants (inclusion/exclusion) and procedures used to assess outcome measures? Is the analytic approach appropriate to the study goals? Do the study conclusions flow from the results? Are study limitations recognized?

Innovation: Does the project challenge and shift current research or clinical practice paradigms by utilizing novel theoretical concepts, approaches or methodologies, instrumentation or interventions?

Impact of Study: Does the project address an important problem or a critical barrier to progress in the field of women's health at midlife and beyond? Does the project improve scientific knowledge, technical capability and/or clinical practice? Does the project change the concepts, methods technologies, treatments, services, or preventative interventions that drive the field of women's health at midlife and beyond?

Clarity: Is the research study presented in a clear and easily understandable manner? Are the goals of the science, the findings, and the interpretation readily accessible to the audience?

Notification of Receipt and Acceptance

  • Receipt of abstract submissions will be acknowledged via email to the contact author.
  • After the review process is complete, authors will be notified by July 15, 2022, regarding the acceptance or rejection of their submissions.  

Cancellations

Authors of accepted presentations who do not present their work or fail to have it presented by a co-author will not be permitted to have abstracts considered for presentation at the NAMS Annual Meeting for the following two years. Exceptions will be considered if NAMS is given prompt notification of extreme unforeseen circumstances.

 

 

 




会议对象: 医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。


免责条款:本站信息均收集整理自互联网,访问者如需了解更多详情,请进入相关活动官网,本站不对相关信息的准确性承担任何责任; 若本站的资讯侵害您的权益,请发送邮件到[email protected],本站将在核实相关情况后第一时间删除。继续访问本站视为认同以上条款。


更多会议活动:
2019年第38届国际胎儿医学与外科学会年会(IFMSS)
2022年北美更年期学会年会
2021 KAPARD-APAPARI联合大会
2022年第15届阿尔茨海默病临床试验大会(CTAD)
2022年第67届日本人类遗传学会年会
2020年国际儿科神经肿瘤学研讨会(ISPNO 2020)
2022年澳大利亚和新西兰围产期学会年会(PSANZ)
2022年第24届国际生育学会联盟世界大会(IFFS)
2021年第32届国际助产士联合会(ICM)大会
2022年第48届美国妇外科医师学会年会


© www.canhui.org | 免责条款 | 提交活动信息 More information contact [email protected]